Twinbeech Capital LP Amgen Inc Transaction History
Twinbeech Capital LP
- $4.99 Billion
- Q3 2024
A detailed history of Twinbeech Capital LP transactions in Amgen Inc stock. As of the latest transaction made, Twinbeech Capital LP holds 1,869 shares of AMGN stock, worth $530,833. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,869Holding current value
$530,833% of portfolio
0.01%Shares
5 transactions
Others Institutions Holding AMGN
# of Institutions
3,083Shares Held
401MCall Options Held
7.56MPut Options Held
7.16M-
Vanguard Group Inc Valley Forge, PA52.4MShares$14.9 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$13.1 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$8.33 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$4.17 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$4.05 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $152B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...